Boston Scientific Corporation today announced it has entered into a definitive agreement to acquire Bolt Medical, Inc., the developer of an intravascular lithotripsy (IVL) advanced laser-based ...
Recent Australian trends indicate that shave biopsies for diagnosing lesions suspicious of melanoma are increasing, yet reasons for this remain relatively unknown. We sought to understand which ...
In one analysis, 16% of men with no suspicious lesions on MRI had clinically significant prostate cancer identified after ...
Boston Scientific inks a new agreement to acquire Bolt Medical, developer of Bolt IVL, for approximately $443 million.
ScreenPoint Medical today announced the acquisition of Biomediq A/S, a research-based company focused on the research, ...
Artificial intelligence has the potential to improve the analysis of medical image data. For example, algorithms based on deep learning can determine the location and size of tumors. This is the ...
Boston Scientific Corporation (NYSE:BSX) agreed to acquire Bolt Medical, Inc., the developer of an intravascular lithotripsy ...
Calcipotriol-plus–5-FU therapy activates immune pathways, offering long-lasting protection against squamous cell carcinoma by ...
Boston Scientific (NYSE: BSX) announced today that it agreed to acquire intravascular lithotripsy (IVL) platform developer ...
Cervical cancer remains a major health threat for women globally, with the highest incidence in developing nations. Despite ...
Slug-inspired adhesive hydrogel, DenTAl, offers advanced oral wound repair, drug delivery, and sutureless healing for chronic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback